TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -11.42%1.1B | -166.51%-339.29M | --1.25B | -62.17%510.16M | ---- | -29.99%1.35B | ---- | -8.69%1.93B | ---- | 26.44%2.11B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -5.46%-23.11M | ---- | 5.14%-21.92M | ---- | -32.39%-23.1M | ---- | -8.09%-17.45M | ---- | 37.69%-16.15M |
Attributable subsidiary (profit) loss | ---- | -115.06%-1.66M | ---- | 119.02%11.05M | ---- | -398.39%-58.08M | ---- | 296.80%19.46M | ---- | -6,359.49%-9.89M |
Impairment and provisions: | ---- | 1,291.74%415.49M | ---- | 2,770.58%29.85M | ---- | -86.18%1.04M | ---- | --7.52M | ---- | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | 2,348.06%380.09M | ---- | --15.53M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | --35.41M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | 1,277.69%14.33M | ---- | -86.18%1.04M | ---- | --7.52M | ---- | ---- |
Revaluation surplus: | ---- | -54.31%44M | ---- | --96.3M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | -54.31%44M | ---- | --96.3M | ---- | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | 99.80%-37K | ---- | -1,178.68%-18.77M | ---- | -282.29%-1.47M | ---- | -145.23%-384K | ---- | 41.26%849K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---21.39M | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -101.41%-37K | ---- | 278.68%2.62M | ---- | -282.29%-1.47M | ---- | -145.23%-384K | ---- | 41.26%849K |
Depreciation and amortization: | ---- | 4.67%967.97M | ---- | 23.72%924.79M | ---- | 25.66%747.48M | ---- | 52.61%594.84M | ---- | 34.21%389.78M |
-Amortization of intangible assets | ---- | 3.34%628.42M | ---- | 14.66%608.12M | ---- | 30.66%530.39M | ---- | 65.61%405.92M | ---- | 45.32%245.11M |
Financial expense | ---- | 11.31%824.83M | ---- | -0.12%741M | ---- | 36.48%741.86M | ---- | 44.22%543.56M | ---- | 86.23%376.89M |
Exchange Loss (gain) | ---- | 423.98%12.61M | ---- | 104.07%2.41M | ---- | -287.10%-59.06M | ---- | -335.23%-15.26M | ---- | 123.57%6.49M |
Special items | ---- | 891.04%318.14M | ---- | --32.1M | ---- | ---- | ---- | 10,736.90%216.74M | ---- | --2M |
Operating profit before the change of operating capital | -11.42%1.1B | -3.82%2.22B | --1.25B | -14.47%2.31B | ---- | -17.65%2.7B | ---- | 14.54%3.28B | ---- | 35.61%2.86B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 61.05%-32.03M | ---- | 18.28%-82.22M | ---- | -516.54%-100.61M | ---- | 125.68%24.15M | ---- | -406.30%-94.05M |
Accounts receivable (increase)decrease | 168.71%481.45M | -72.14%-1.98B | ---700.73M | 64.70%-1.15B | ---- | -77.11%-3.26B | ---- | -221.67%-1.84B | ---- | 24.73%-571.42M |
Accounts payable increase (decrease) | ---- | 192.46%59.84M | ---- | -122.35%-64.72M | ---- | 86.95%289.53M | ---- | -70.51%154.87M | ---- | 11.21%525.18M |
Special items for working capital changes | ---- | 78.30%-304.57M | ---- | -254.62%-1.4B | ---- | 139.00%907.78M | ---- | 13.90%-2.33B | ---- | -35.63%-2.7B |
Cash from business operations | 1,300.03%1.06B | 90.80%-36.15M | 86.09%-87.93M | -172.94%-392.86M | -343.78%-632.28M | 175.70%538.57M | 126.53%259.37M | -4,668.73%-711.49M | -484.72%-977.47M | 108.18%15.57M |
China income tax paid | 0.83%-67.12M | -130.49%-112.57M | -103.17%-67.68M | 63.82%-48.84M | 58.81%-33.31M | 30.35%-134.98M | 8.16%-80.87M | -14.38%-193.81M | -34.91%-88.06M | -121.63%-169.44M |
Interest received - operating | -0.77%13.81M | 5.46%23.11M | 68.42%13.92M | -5.14%21.92M | -7.30%8.27M | 32.39%23.1M | -5.36%8.92M | 8.09%17.45M | 37.11%9.42M | -37.69%16.15M |
Net cash from operations | 807.10%1B | 70.08%-125.6M | 78.44%-141.69M | -198.38%-419.78M | -450.75%-657.33M | 148.06%426.69M | 117.75%187.41M | -544.68%-887.85M | -368.19%-1.06B | 42.83%-137.72M |
Cash flow from investment activities | ||||||||||
Decrease in deposits (increase) | 87.13%-1.41M | 100.00%-1K | 56.88%-10.96M | -1,556.54%-24.6M | -1,610.88%-25.41M | -91.92%1.69M | -92.40%1.68M | 477.06%20.91M | --22.14M | -100.81%-5.55M |
Sale of fixed assets | --131K | --167K | ---- | ---- | 272.34%1.64M | 111.52%2.39M | -84.78%441K | 14.40%1.13M | 1,280.00%2.9M | 39.86%986K |
Purchase of fixed assets | 58.89%-145.14M | 14.48%-505.96M | 18.83%-353.03M | 53.43%-591.6M | 42.84%-434.91M | -67.05%-1.27B | -440.12%-760.83M | -35.45%-760.47M | 46.34%-140.87M | -25.44%-561.45M |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | --15.47M | ---- | ---- | ---- | ---- |
Purchase of intangible assets | 67.49%-184.58M | 11.14%-855.43M | -10.52%-567.75M | 35.17%-962.63M | 45.10%-513.73M | 32.14%-1.48B | -4.41%-935.73M | 33.52%-2.19B | 48.08%-896.22M | -32.05%-3.29B |
Sale of subsidiaries | ---- | ---- | ---- | --60.05M | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | 100.61%261K | --261K | 82.94%-43.05M | ---- | ---252.3M |
Cash on investment | ---- | 65.96%-22.59M | 65.96%-22.59M | -1,695.97%-66.34M | -1,713.15%-66.34M | 95.58%-3.69M | -85.55%-3.66M | 50.63%-83.58M | 82.89%-1.97M | -44.43%-169.32M |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | 70.38%-62.21M | ---- | ---210.01M | ---- | ---- |
Net cash from investment operations | 65.32%-331M | 12.70%-1.38B | 8.13%-954.33M | 43.42%-1.59B | 38.82%-1.04B | 14.15%-2.8B | -67.44%-1.7B | 23.74%-3.26B | 54.79%-1.01B | -80.59%-4.28B |
Net cash before financing | 161.21%670.92M | 24.71%-1.51B | 35.38%-1.1B | 15.57%-2B | -12.29%-1.7B | 42.79%-2.37B | 27.04%-1.51B | 6.02%-4.15B | 16.14%-2.07B | -69.20%-4.42B |
Cash flow from financing activities | ||||||||||
New borrowing | -62.35%2.08B | 6.02%9.24B | 7.23%5.53B | 29.75%8.71B | 57.20%5.16B | 0.67%6.71B | 14.78%3.28B | 5.73%6.67B | -1.05%2.86B | 94.47%6.31B |
Refund | 12.58%-3.69B | 10.63%-7.67B | 3.14%-4.22B | -81.23%-8.59B | -199.34%-4.36B | -20.55%-4.74B | 18.39%-1.46B | -279.40%-3.93B | -264.89%-1.78B | -104.71%-1.04B |
Issuance of bonds | -4.19%1.08B | -3.84%2.2B | -50.63%1.13B | 90.03%2.28B | --2.28B | 10.12%1.2B | ---- | --1.09B | --1.09B | ---- |
Interest paid - financing | 1.25%-419.57M | -14.10%-817.04M | -14.96%-424.9M | -3.42%-716.05M | -2.54%-369.6M | -28.95%-692.39M | -34.73%-360.44M | -33.93%-536.93M | -59.30%-267.52M | -88.13%-400.9M |
Dividends paid - financing | ---- | 67.11%-51.65M | ---- | 46.15%-157.02M | 42.86%-82.64M | 14.04%-291.61M | 14.30%-144.63M | -13.24%-339.25M | -25.67%-168.77M | 3.33%-299.58M |
Absorb investment income | ---- | ---- | ---- | -66.48%8.05M | -50.92%7.12M | -69.35%24.02M | -56.51%14.52M | -18.65%78.37M | 242.20%33.38M | 38.19%96.33M |
Issuance expenses and redemption of securities expenses | ---- | ---907.25M | ---928.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Pledged bank deposit (increase) decrease | -60.57%14.91M | -65.25%26.13M | -18.96%37.81M | 15.99%75.19M | -49.27%46.66M | 510.39%64.83M | 673.71%91.97M | -458.29%-15.8M | -61.04%11.89M | 192.20%4.41M |
Other items of the financing business | -99.29%-39.99M | -916.26%-34.28M | 95.84%-20.07M | 159.81%4.2M | -2,490.35%-481.86M | -100.88%-7.02M | -568.68%-18.6M | 85.57%794.7M | -99.13%3.97M | 10,936.36%428.25M |
Net cash from financing operations | -188.74%-975.03M | 21.58%1.97B | -50.09%1.1B | -28.69%1.62B | 56.44%2.2B | -40.27%2.27B | -20.79%1.41B | -25.33%3.81B | -31.46%1.78B | 124.02%5.1B |
Effect of rate | 34.89%-19.58M | 70.21%-58.23M | 74.27%-30.08M | -349.46%-195.44M | -304.49%-116.89M | -52.35%78.35M | 285.76%57.16M | 503.62%164.41M | -323.30%-30.77M | -64.79%-40.73M |
Net Cash | -11,422.23%-304.12M | 220.52%462.02M | -99.47%2.69M | -280.48%-383.34M | 589.27%505.27M | 70.70%-100.75M | 64.84%-103.27M | -150.47%-343.9M | -338.28%-293.69M | 303.62%681.37M |
Begining period cash | 21.20%2.31B | -23.30%1.9B | -23.30%1.9B | -0.89%2.48B | -0.89%2.48B | -6.68%2.51B | -6.68%2.51B | 31.33%2.69B | 31.33%2.69B | -14.95%2.04B |
Cash at the end | 5.73%1.98B | 21.20%2.31B | -34.63%1.88B | -23.30%1.9B | 16.75%2.87B | -0.89%2.48B | 4.19%2.46B | -6.68%2.51B | 9.26%2.36B | 31.33%2.69B |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | 11.53%2.41B | 17.11%2.21B | --2.16B | --1.88B |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | 11.53%2.41B | 17.11%2.21B | --2.16B | --1.88B |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.